BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2016

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia

Résumé

Approximately 30% of the patients who fulfil the criteria of Waldenström's macroglobulinemia (WM) are diagnosed while asymptomatic (indolent), and will not require immediate therapy. Conversely, patients with a disease-related event will be considered for therapy. The physiopathology of these 2 groups remains unclear, and the mechanisms of progression from indolent to symptomatic WM have yet to be fully understood. Seventeen patients diagnosed with WM were included in this study, 8 asymptomatic WM (A-WM) and 9 symptomatic WM (S-WM). A differential analysis was performed on a first series of 11 patients and identified 48 genes whose expression separated samples from A-to S-WM. This gene signature was then confirmed on a second independent validation set of 6 WM. Within this expression profile, BACH2, a B-cell transcription factor known to be a tumor suppressor gene, was found to be over-expressed in A-MW relatively to S-MW. We specifically over-expressed BACH2 in a WM-related cell line and observed a significant reduction of the clonogenic activity. To the best of our knowledge, we report for the first time a specific gene expression signature that differentiates A-WM and S-WM. Within this expression profile, BACH2 was identified as a candidate gene that may help to understand better the behavior of tumor cells in indolent WM.
Fichier principal
Vignette du fichier
Herbaux2016.pdf (5.18 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-01423307 , version 1 (29-12-2016)

Identifiants

  • HAL Id : hal-01423307 , version 1

Citer

Charles Herbaux, Elisabeth Bertrand, Guillemette Marot, Christophe Roumier, Nicolas Poret, et al.. BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia. Oncotarget, 2016. ⟨hal-01423307⟩
205 Consultations
102 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More